There is no conclusive long-term human data, so its recommended to use BPC-157 under the guidance of a healthcare provider
of malignancy for patients with less extensive UC (with involvement of the colon distal to the splenic flexure) also is increased, but the magnitude of the risk has not been defined
Only a couple of preliminary experiments have involved BPC-157 and animals with pre-existing cancer, which have investigated the potential effects of the peptide on tumor cells
AOD 9604 is a synthetic peptide fragment derived from human growth hormone, designed to promote fat breakdown without affecting growth or blood sugar levels
But theres tension here, both scientifically and culturally
(Scientific Reports, 2021) reported that NNMT inhibition plus a lean-diet substitution lowered body weight, fat mass, and liver fat beyond either intervention alone